According to Actinium Pharmaceuticals's latest financial reports the company's total assets are $88.35 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.11 B | 42.05% |
2021-12-31 | $80.38 M | 21.07% |
2020-12-31 | $66.39 M | 468.95% |
2019-12-31 | $11.67 M | -21.62% |
2018-12-31 | $14.88 M | -18.8% |
2017-12-31 | $18.33 M | -18.61% |
2016-12-31 | $22.52 M | -15.27% |
2015-12-31 | $26.58 M | 251.27% |
2014-12-31 | $7.56 M | 31.28% |
2013-12-31 | $5.76 M | -0.4% |
2012-12-31 | $5.78 M | -6.64% |
2011-12-31 | $6.2 M | 4133564.67% |
2010-12-31 | $0 M | -92.93% |
2009-12-31 | $0 M | -4.33% |
2008-12-31 | $0 M | -4.15% |
2007-12-31 | $0 M | 396.57% |
2006-12-31 | $0 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Genocea Biosciences
GNCA | $38.78 M | -56.10% | ๐บ๐ธ USA |
Amicus Therapeutics
FOLD | $0.77 B | 780.43% | ๐บ๐ธ USA |
BioMarin Pharmaceutical BMRN | $6.87 B | 7,678.74% | ๐บ๐ธ USA |